10% ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE DUE June 28, 2017Guided Therapeutics Inc • December 30th, 2016 • Electromedical & electrotherapeutic apparatus • New York
THIS 10% ORIGINAL ISSUE DISCOUNT CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 10% Convertible Notes of Guided Therapeutics, Inc., a Delaware corporation, (the “Company”), having its principal place of business at 5835 Peachtree Corners East, Suite D, Norcross, Georgia 30092, designated as its 10% Original Issue Discount Convertible Promissory Note, due June 28, 2017 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 30th, 2016 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 28, 2016, between Guided Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
